Skip to content
SFB-Pharma

SFB-Pharma

  • Office
  • Contact
  • About Us
Scroll down to content

Posts

Posted on 7 January 20207 January 2020

Bienvenue dans – Welkom bij:

Bienvenidos en – Welcome to:

SFB-Pharma

If you want to reach me please send a message to:

Christine Laroche  claroche@sfb-pharma.com

Recent Posts

  • (no title)

Archives

  • January 2020

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS Drugs.com – New Drug Approvals

  • U.S. FDA Approves Yescarta for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy
  • FDA Approves Azstarys (serdexmethylphenidate and dexmethylphenidate) Capsules for the Once-Daily Treatment for ADHD
  • FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A
  • FDA Approves Pepaxto (melphalan flufenamide) for Patients with Relapsed or Refractory Multiple Myeloma

RSS Pharma Manufacturing News

  • Johnson & Johnson’s Covid-19 vaccine receives interim order authorisation in Canada
  • Amgen signs agreement to acquire Five Prime Therapeutics for $1.9bn
  • Bharat Biotech’s Phase III interim results of COVAXIN demonstrate efficacy of 81%

SFB-Pharma Info

  • About Us
  • Contact
  • Office

RSS White papers and Web seminars

  • Fireside Chat with Tandem Health & Cisco Meraki
  • Massive Interoperability: High-Performance Data Sharing at Scale
  • The Prescription for a Superior Healthcare Network
  • The Actively Connected Physician: How CMS Mandated ADT Event Notifications Lead to Improved Patient Care
Proudly powered by WordPress
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok